Neoantigen polypeptide vaccine Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 2/3: 1

Top Sponsors

Second Affiliated Hospital of Wenzhou Medical University1
Second Affiliated Hospital of Guangzhou Medical University1

Indications

Cancer2
Epithelial Ovarian Cancer1
Solid Tumor, Adult1

Other2 trials

Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors

Phase 1

Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.